$17.25
6.40% today
NYSE, Apr 04, 08:44 pm CET
ISIN
US4270965084
Symbol
HTGC
Sector
Industry

Hercules Capital Stock price

$18.43
-2.13 10.36% 1M
-1.17 5.95% 6M
-1.59 7.96% YTD
+0.39 2.14% 1Y
+1.41 8.29% 3Y
+12.40 205.45% 5Y
+6.19 50.62% 10Y
NYSE, Closing price Thu, Apr 03 2025
-0.63 3.31%
ISIN
US4270965084
Symbol
HTGC
Sector
Industry

Key metrics

Market capitalization $3.30b
Enterprise Value $4.97b
EV/FCF (TTM) EV/FCF 16.56
EV/Sales (TTM) EV/Sales 10.76
P/S ratio (TTM) P/S ratio 7.14
Dividend yield 9.03%
Last dividend (FY24) $1.98
Revenue growth (TTM) Revenue growth -1.49%
Revenue (TTM) Revenue $462.11m
EBIT (operating result TTM) EBIT $340.29m
Free Cash Flow (TTM) Free Cash Flow $300.16m
Cash position $116.42m
EPS (TTM) EPS $1.61
P/E forward 9.39
P/S forward 6.19
EV/Sales forward 9.32
Short interest 3.65%
Show more

Is Hercules Capital a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Hercules Capital Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Hercules Capital forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Hercules Capital forecast:

Buy
67%
Hold
33%

Financial data from Hercules Capital

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
462 462
1% 1%
100%
- Direct Costs 9.27 9.27
8% 8%
2%
453 453
1% 1%
98%
- Selling and Administrative Expenses 112 112
108% 108%
24%
- Research and Development Expense - -
-
-
341 341
16% 16%
74%
- Depreciation and Amortization 0.47 0.47
147% 147%
0%
EBIT (Operating Income) EBIT 340 340
16% 16%
74%
Net Profit 260 260
22% 22%
56%

In millions USD.

Don't miss a Thing! We will send you all news about Hercules Capital directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hercules Capital Stock News

Neutral
Business Wire
9 days ago
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), for up to $200 million. Access to the additional capital strengthens Savara's balance sheet following the submission of the Biol...
Positive
Seeking Alpha
12 days ago
Hercules Capital is one of the best BDC with a 20-year history, offering a 10.4% dividend yield and a +1,040% total return since inception. HTGC's strong financials, including recent record-high TII and NII, ensure sustainable dividends and long-term stability. The recent 19% pullbacks give a decent buy signal, despite the stock's premium P/NAV valuation.
Neutral
ETF Trends
13 days ago
A friend of mine keeps posting every day about how much money she has lost in the stock market. I finally had to comment on her post: “Stop checking your account.
More Hercules Capital News

Company Profile

Head office United States
CEO Scott Bluestein
Employees 100
Founded 2003
Website www.htgc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today